KRH3955, identified by its CAS number 1097732-62-1, is a chemical compound that has garnered attention in the field of medicinal chemistry. While specific details about its characteristics may not be widely available, compounds like KRH3955 are typically evaluated for their biological activity, stability, solubility, and potential therapeutic applications. Such substances often undergo rigorous testing to determine their efficacy and safety profiles, particularly if they are being developed as pharmaceuticals. The molecular structure, functional groups, and interactions with biological targets are crucial for understanding its mechanism of action. Additionally, the compound's physicochemical properties, such as melting point, boiling point, and spectral data, are essential for characterizing its behavior in various environments. As research progresses, more detailed information regarding KRH3955's characteristics and applications may emerge, contributing to its potential use in medical or industrial applications.

KRH3955

1097732-62-1: KRH3955, identified by its CAS number 1097732-62-1, is a chemical compound that has garnered attention in the field of medicinal chemistry. While specific details about its characteristics may not be widely available, compounds like KRH3955 are typically evaluated for their biological activity, stability, solubility, and potential therapeutic applications. Such substances often undergo rigorous testing to determine their efficacy and safety profiles, particularly if they are being developed as pharmaceuticals. The molecular structure, functional groups, and interactions with biological targets are crucial for understanding its mechanism of action. Additionally, the compound's physicochemical properties, such as melting point, boiling point, and spectral data, are essential for characterizing its behavior in various environments. As research progresses, more detailed information regarding KRH3955's characteristics and applications may emerge, contributing to its potential use in medical or industrial applications.

KRH-3955, a CXCR4 antagonist, is an orally bioavailable and extremely potent inhibitor of HIV-1 infection.

KRH-3955 Salt

A potent antagonist of chemokine receptors CXCR4, inhibiting both the binding of SDF-1α and Ca2+ signaling. KRH 3955 also potently inhibits the replication of X4 HIV-1, including recombinant X4 HIV-1 with mutations conferring resistance to NRTIs, NNRTIs, PIs and T20. KRH 3955 may have therapeutic potential in diseases involving CXCR4-SDF-1 interaction, such as cancer, leukaemia, rheumatoid arthritis and pulmonary fibrosis.

CAS 1097732-62-1

KRH3955

KRH-3955 Salt

Ref: TM-T27742

KRH 3955

Ref: 3D-BK167284